Research
Print page Print page
Switch language
Bispebjerg Hospital - a part of Copenhagen University Hospital
Published

Gastrin secretion in normal subjects and diabetes patients is inhibited by glucagon-like peptide 1: a role in the gastric side effects of GLP-1-derived drugs?

Research output: Contribution to journalJournal articleResearchpeer-review

  1. The clinical course of common bile duct stone clearance with endoscopic retrograde cholangio-pancreaticography

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Long term treatment with stimulant laxatives - clinical evidence for effectiveness and safety?

    Research output: Contribution to journalReviewResearchpeer-review

  3. Childhood growth and risk of inflammatory bowel disease: a population-based study of 317,030 children

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Quality of life, performance status, and work capacity after post-endoscopic retrograde cholangiopancreatography pancreatitis

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Influenza and risk of later celiac disease: a cohort study of 2.6 million people

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. The renal extraction and the natriuretic action of GLP-1 in humans depend on interaction with the GLP-1 receptor

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Increased oral sodium chloride intake in humans amplifies selectively postprandial GLP-1 but not GIP, CCK, and gastrin in plasma

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. The Natriuretic Action of Glucagon-Like Peptide-1 in Humans Is Abolished by the GLP-1 Receptor Antagonist Exendin 9-39

    Research output: Contribution to conferencePosterResearchpeer-review

  4. Extracellular fluid volume expansion uncovers a natriuretic action of GLP-1: a functional GLP-1-renal axis in man

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. GIP-induced vasodilation in human adipose tissue involves capillary recruitment

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Background: Randomized and controlled trials of glucagon-like peptide-1 (GLP-1) derived drugs have shown that the most frequent adverse symptoms are gastrointestinal. Some of the side effects such as dyspepsia, nausea and upper abdominal pain may well be of gastric origin. Since the antral hormone gastrin regulates gastric secretion of acid and enzymes and contributes to the regulation of gastric motility, we examined the effect of GLP-1 on the secretion of gastrin in normal subjects and diabetes patients.Method: Plasma was sampled from ten healthy subjects and ten patients with diabetes mellitus type 1 with glucose clamped between 6 and 9 mM. GLP-1 or saline were infused for 4 h during and after a meal. Plasma concentrations of gastrin and GLP-1 were measured using specific radioimmunoassays.Results: Basal plasma concentrations of gastrin were similar in controls and patients. After the meal, the gastrin concentrations rose significantly during saline infusion, whereas the GLP-1 infusion suppressed the secretion of gastrin significantly, most pronounced in the diabetes patients.Conclusions: The results show that GLP-1 infusion suppresses the postprandial secretion of gastrin in normal subjects and even more so in the diabetes patients. The results may therefore shed further light on the upper gastrointestinal side effects of GLP-1-derived drugs in diabetic patients.

Original languageEnglish
JournalScandinavian Journal of Gastroenterology
Volume54
Issue number12
Pages (from-to)1448-1451
Number of pages4
ISSN0036-5521
DOIs
Publication statusPublished - 2 Dec 2019

ID: 58382529